According to monitoring by Beating, court documents leaked from Elon Musk's lawsuit against OpenAI revealed a wealth cycle in which Sam Altman uses OpenAI's commercial contracts to inflate the valuation of his personal investments. Since Altman does not hold equity in OpenAI, his financial returns rely entirely on external startups where he has invested. The operation model of this wealth cycle involves OpenAI signing procurement contracts or cooperation agreements to enhance the valuation of startups, subsequently attracting major shareholders of OpenAI (such as Thrive Capital) or partners (like SoftBank) to invest at a high premium, thereby allowing Altman to directly realize a surge in personal wealth. In June 2026, after Thrive Capital, a major shareholder of OpenAI, invested in the fusion company Helion at a valuation of $15.5 billion, insiders revealed that Altman's personal stake in Helion had doubled to at least $4.1 billion. In 2025, Altman had requested OpenAI to invest approximately $500 million in Helion, which caused unease among some employees, and OpenAI subsequently rejected the investment; however, both parties signed a revised cooperation agreement in March 2026, and Altman stepped down from his position on Helion's board that same month to avoid conflicts of interest. Additionally, after chipmaker Cerebras secured a commitment for chip procurement from OpenAI and successfully completed its IPO, Altman's stake in Cerebras surged more than sixfold compared to December 2025. Furthermore, following a research collaboration between longevity startup Retro Biosciences and OpenAI, evidence disclosed in Elon Musk's lawsuit indicated that Altman's stake in Retro had reached $258 million by December 2025. Currently, at least ten companies in which Altman has invested are involved in related transactions with OpenAI, prompting the U.S. House Oversight Committee to launch a formal investigation, while several state attorneys general have called for the U.S. Securities and Exchange Commission to review Altman.